![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Cabotegravir Has No Effect on Cardiac Repolarization in Healthy Subjects
|
|
|
Reported by Jules Levin, NATAP
ICAAC 2015
55th Interscience Conference of Antimicrobial Agents and Chemotherapy,September 17-21, 2015, San Diego, California
Y. LOU1, S. CHEN2, E. GOULD1, A. BUCHANAN3, S. FORD1, P. PATEL3
1 PAREXEL International (formerly of GlaxoSmithKline)
2 GlaxoSmithKline
3 ViiV Healthcare
![ICAAC1.gif](../images/092115/092115-7/ICAAC1.gif)
![ICAAC2.gif](../images/092115/092115-7/ICAAC2.gif)
![ICAAC3.gif](../images/092115/092115-7/ICAAC3.gif)
![ICAAC4.gif](../images/092115/092115-7/ICAAC4.gif)
![ICAAC5.gif](../images/092115/092115-7/ICAAC5.gif)
![ICAAC6.gif](../images/092115/092115-7/ICAAC6.gif)
![ICAAC7.gif](../images/092115/092115-7/ICAAC7.gif)
![ICAAC8.gif](../images/092115/092115-7/ICAAC8.gif)
![ICAAC9.gif](../images/092115/092115-7/ICAAC9.gif)
![ICAAC10.gif](../images/092115/092115-7/ICAAC10.gif)
![ICAAC11.gif](../images/092115/092115-7/ICAAC11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|